Westhampton Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Hold
4,775
0.16% 98
2026
Q1
$414K Sell
4,775
-900
-16% -$86.2K 0.19% 91
2025
Q4
$545K Buy
5,675
+50
+0.9% +$4.86K 0.26% 82
2025
Q3
$536K Hold
5,625
0.26% 85
2025
Q2
$490K Sell
5,625
-700
-11% -$59.4K 0.25% 85
2025
Q1
$568K Hold
6,325
0.31% 81
2024
Q4
$505K Sell
6,325
-200
-3% -$17.3K 0.26% 86
2024
Q3
$587K Sell
6,525
-1,000
-13% -$84.1K 0.3% 84
2024
Q2
$592K Hold
7,525
0.32% 82
2024
Q1
$656K Buy
7,525
+800
+12% +$68.3K 0.36% 78
2023
Q4
$554K Buy
6,725
+650
+11% +$49.5K 0.33% 82
2023
Q3
$476K Hold
6,075
0.31% 82
2023
Q2
$535K Sell
6,075
-100
-2% -$8.61K 0.35% 75
2023
Q1
$498K Buy
6,175
+800
+15% +$65.2K 0.32% 85
2022
Q4
$418K Sell
5,375
-925
-15% -$75K 0.28% 89
2022
Q3
$509K Buy
6,300
+700
+13% +$62.9K 0.38% 77
2022
Q2
$503K Buy
5,600
+300
+6% +$30.4K 0.36% 78
2022
Q1
$588K Buy
+5,300
New +$560K 0.38% 76

Other funds holding MDT

Westhampton Capital's MDT Position: Q2 2026 in Review

Westhampton Capital held its Medtronic (MDT) position steady in Q2 2026 at 4,775 shares worth $374K. The position accounts for 0.16% of the portfolio, ranked #98.

Westhampton Capital first reported a position in MDT in Q1 2022 and has held it in 18 quarters since. The position peaked at $656K in Q1 2024. 729 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Westhampton Capital held 4,775 shares of Medtronic worth $374K as of Q2 2026.
  • Westhampton Capital left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.16% of Westhampton Capital's portfolio in Q2 2026, its #98 holding.
  • Westhampton Capital first reported a position in Medtronic in Q1 2022 and has held it in 18 quarters since.
  • Westhampton Capital's Medtronic position peaked at $656K in Q1 2024.
  • 729 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.